Market revenue in 2022 | USD 121,705.4 million |
Market revenue in 2030 | USD 215,158.9 million |
Growth rate | 7.4% (CAGR from 2022 to 2030) |
Largest segment | Drug discovery |
Fastest growing segment | Nanorobotics for Drug Delivery |
Historical data covered | 2017 - 2021 |
Base year for estimation | 2022 |
Forecast period covered | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Nanorobotics for Drug Delivery, Regenerative Medicine, Diagnostic and Biological, Bioelectronics, Engineered Living Materials, Optogenetics, Precision Medicine |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare bioconvergence market will help companies and investors design strategic landscapes.
drug discovery was the largest segment with a revenue share of 20.16% in 2022. Horizon Databook has segmented the Global healthcare bioconvergence market based on drug discovery, nanorobotics for drug delivery, regenerative medicine, diagnostic and biological, bioelectronics, engineered living materials, optogenetics, precision medicine covering the revenue growth of each sub-segment from 2017 to 2030.
Horizon Databook provides a detailed overview of global-level data and insights on the Global healthcare bioconvergence market, including forecasts for subscribers. This global databook contains high-level insights into Global healthcare bioconvergence market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account